Vertellus, a producer of specialty chemicals for the life sciences sector and other industrial applications, signed a definitive agreement to acquire the sodium borohydride (SBH) business, including associated assets, from The Dow Chemical Company. Sodium borohydride is predominantly used as a critical synthesis and process aid in the production of active pharmaceutical ingredients including high growth antiretrovirals for the treatment of HIV/AIDS. It is also used in bleaching applications, such as mechanical wood pulping for newspaper and tissue production.
The acquisition accelerates Vertellus’ strategy to expand its product offerings in the life science sector through both organic growth and strategic acquisitions. Revenues from life science applications represent more than 65% of the company’s total revenue, and Vertellus expects the acquisition will significantly increase its ability to provide tailored solutions to the pharmaceutical and agriculture sector.
The transaction is expected to close in the first quarter of 2015.
For more information, visit: www.vertellus.com
